Does RISANKIZUMAB-RZAA Cause Post procedural complication? 232 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 232 reports of Post procedural complication have been filed in association with RISANKIZUMAB-RZAA. This represents 0.4% of all adverse event reports for RISANKIZUMAB-RZAA.
232
Reports of Post procedural complication with RISANKIZUMAB-RZAA
0.4%
of all RISANKIZUMAB-RZAA reports
5
Deaths
79
Hospitalizations
How Dangerous Is Post procedural complication From RISANKIZUMAB-RZAA?
Of the 232 reports, 5 (2.2%) resulted in death, 79 (34.1%) required hospitalization, and 2 (0.9%) were considered life-threatening.
Is Post procedural complication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 232 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Post procedural complication?
ADALIMUMAB (2,494)
ETANERCEPT (318)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (244)
UPADACITINIB (241)
INFLIXIMAB (217)
METHOTREXATE (188)
TREPROSTINIL (174)
HUMAN IMMUNOGLOBULIN G (159)
PREDNISONE (157)
CARBIDOPA\LEVODOPA (156)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Post procedural complication Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA